• Unraveling Mitochondrial Dysfunction: Advanced TMRE Assay St

  2026-06-30

  Explore the mechanistic underpinnings of mitochondrial ROS in toxin-induced hepatotoxicity and discover how Tetramethylrhodamine ethyl ester perchlorate (TMRE, SKU: C8197) empowers translational researchers to design more sensitive, disease-relevant live-cell mitochondrial membrane potential assays. This article bridges foundational mitochondrial biology, the latest mechanistic discoveries, and actionable assay innovation—delivering a roadmap for researchers navigating the evolving landscape of mitochondrial imaging and dysfunction research.

• SP600125 in Translational Research: Mechanistic Clarity & St

  2026-06-30

  This thought-leadership article unpacks the mechanistic role of SP600125—a highly selective, reversible, ATP-competitive JNK inhibitor—in modulating inflammation, apoptosis, and cytokine expression. Bridging foundational MAPK pathway biology with advanced translational strategies, we provide actionable guidance for researchers aiming to leverage JNK inhibition in disease modeling, experimental design, and therapeutic innovation. Drawing on recent peer-reviewed evidence, leading workflow enhancements, and the latest insights from orofacial pain research, this piece charts a visionary path for translational scientists ready to redefine the impact of JNK pathway modulation.

• KN-62: Selective CaMKII Inhibitor for Calcium Signaling Rese

  2026-06-29

  KN-62, 1-[N,O-bis-(5-isoquinolinesulphonyl)-N-methyl-L-tyrosy]-4-phenylpiperazine, is a potent and highly selective CaMKII inhibitor. It precisely disrupts calcium/calmodulin-dependent signaling, enabling controlled studies of insulin secretion and cell cycle regulation. KN-62’s selectivity and benchmark potency make it indispensable for dissecting calcium signaling pathways in metabolic, neurobiological, and cancer research.

• Dimethyloxalylglycine (DMOG): Technical Use and Protocol Gui

  2026-06-29

  Dimethyloxalylglycine (DMOG) enables researchers to stabilize hypoxia-inducible factors for studies on hypoxia signaling and immune modulation in both in vitro and in vivo models. It should only be used in controlled laboratory settings, not for diagnostic or clinical applications, and requires strict adherence to solubility and storage guidelines for reliable results.

• Tropifexor (LJN452): FXR Agonism for Precision Anti-Fibrotic

  2026-06-28

  Explore how Tropifexor (LJN452), a potent FXR agonist, advances precision anti-fibrotic and metabolic disease research by targeting bile acid signaling and epithelial barrier function. This article uniquely integrates mechanistic depth, protocol guidance, and new cross-talk with anti-fibrotic pathways.

• SmD2 Acetylation Regulates Splicing and PARP Inhibitor Sensi

  2026-06-27

  This study uncovers how acetylation-dependent regulation of SmD2, a core spliceosome component, modulates alternative splicing events in hepatocellular carcinoma (HCC) and impacts DNA damage responses. The findings reveal that targeting SmD2 acetylation enhances HCC cell sensitivity to PARP inhibitors, suggesting a new combinatorial therapeutic approach.

• Cdc42 Inhibition Attenuates Kidney Fibrosis via β-Catenin Mo

  2026-06-26

  A recent study identifies Cdc42 as a key regulator in kidney fibrosis, demonstrating that direct inhibition of Cdc42 dampens pro-fibrotic GSK-3β/β-catenin signaling. These findings reveal a mechanistically defined anti-fibrotic strategy and underscore the value of selective Cdc42 inhibitors for fibrotic disease modeling.

• Cyclophosphamide: Protocols and Troubleshooting for Cancer R

  2026-06-26

  Cyclophosphamide is a gold-standard alkylating chemotherapeutic agent that enables rigorous apoptosis induction and immune modulation in cancer and transplantation studies. This guide delivers actionable protocols, experimental optimizations, and workflow troubleshooting tips—empowering researchers to leverage APExBIO’s Cyclophosphamide for reproducible, high-impact results.

• Cell Cycle Assay Kit: Precision Analysis of G0/G1, S, G2/M P

  2026-06-25

  Unlock high-resolution cell cycle phase and apoptosis analysis with the APExBIO Cell Cycle Assay Kit (Catalog No. K2263). This workflow-driven guide delivers protocol optimizations, troubleshooting strategies, and actionable insights for robust flow cytometry in cancer and translational research.

• EPI-001: Androgen Receptor N-Terminal Domain Inhibitor in Ca

  2026-06-25

  EPI-001 stands apart as a selective androgen receptor N-terminal domain inhibitor, uniquely enabling the disruption of both full-length and splice variant-driven AR signaling in prostate and breast cancer models. This article unpacks practical workflows, troubleshooting strategies, and translational insights for maximizing research outcomes with EPI-001.

• SGI-1027 Downregulates DNMT1 to Restore RB1 in Gastric Cance

  2026-06-24

  This study demonstrates that SGI-1027, a DNA methyltransferase inhibitor, suppresses gastric cancer cell growth and metastasis by downregulating DNMT1 and reactivating the RB1 tumor suppressor gene. These findings provide mechanistic insight into epigenetic modulation as a therapeutic strategy for gastric cancer.

• EPI-001: Expanding the Frontier of Androgen Receptor NTD Inh

  2026-06-23

  Explore how EPI-001, a leading androgen receptor N-terminal domain inhibitor, is reshaping prostate and breast cancer research. Gain new technical insights into its unique mechanism and practical applications, with a focus on advanced assay design and translational relevance.

• Busulfan as a DNA Alkylating Agent: Protocols & Innovations

  2026-06-23

  Busulfan is a proven DNA alkylating agent for inducing cellular senescence and targeted germ cell depletion, underpinning advanced lineage tracing and reproductive biology models. This article distills protocol enhancements, troubleshooting solutions, and the latest genetic tracing breakthroughs to maximize reproducibility with Busulfan from APExBIO.

• EZ Cap™ Firefly Luciferase mRNA: Reporter Performance & Prot

  2026-06-22

  EZ Cap™ Firefly Luciferase mRNA enables robust, sustained bioluminescent reporting in gene regulation assays. Its Cap 1 structure and optimized poly(A) tail enhance translation efficiency and mRNA stability. This dossier details evidence, recommended workflows, and application boundaries for this APExBIO product.

• E. coli Uracil-DNA Glycosylase (UDG): Technical Use & Protoc

  2026-06-22

  E. coli Uracil-DNA Glycosylase (UDG) is designed for selective removal of uracil from DNA, preventing PCR product contamination and supporting DNA damage repair research. It should not be used with RNA, very short oligonucleotides, or in any diagnostic or clinical applications.

16728 records 1/1116 page Next 12345 下5页 Last page